DanielleSylvieRudichMD
Ophthalmology • Waterbury, CTCataract Related, Neuro-Ophthalmology, Retinal Disease
Physician
Dr. Rudich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 W Main St
Ste 100
Waterbury, CT 06708Phone+1 203-597-9100
Summary
- Dr. Danielle Rudich is an ophthalmologist in Waterbury, CT and is affiliated with Yale-New Haven Hospital. She received her medical degree from University of Connecticut School of Medicine and has been in practice 9 years. She specializes in cataract related, neuro-ophthalmology, and retinal disease and is experienced in neuro-ophthalmology and ophthalmology.
Education & Training
New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Neuro-Ophthalmology, 2012 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Ophthalmology, 2009 - 2012
St Vincent's Medical CenterInternship, Transitional Year, 2008 - 2009
Uconn School Of MedicineClass of 2008
Certifications & Licensure
CT State Medical License 2013 - 2025
NY State Medical License 2010 - 2014- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2014
Publications & Presentations
PubMed
- 427 citationsMetastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive EyesCarol L. Shields, Minoru Furuta, Archana Thangappan, Saya Nagori, Arman Mashayekhi
Archives of Ophthalmology. 2009-08-01 - 44 citationsPredictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.Subina Narang, Arman Mashayekhi, Danielle S. Rudich, Carol L. Shields
Clinical & Experimental Ophthalmology. 2012-09-01 - 15 citationsOptic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment TrialMichael Wall, Matthew J. Thurtell, Rudrani Banik, Sanjay Kedhar, Flora Levin
The British Journal of Ophthalmology. 2017-01-27
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
